Profile
Joseph Hooker worked as a Senior Director of Clinical Operations at X4 Pharmaceuticals, Pierian Biosciences LLC, and Sandoz Biopharmaceuticals.
He was also a Director of Program Leadership at Biogen, a President, CEO, CFO, and Chief Accounting Officer at NeuroBo Pharmaceuticals, and a Senior Manager of Clinical Trial at DuPont Merck Pharmaceutical Co. Additionally, he earned a Master's in Business Administration from Rider University and an undergraduate degree from Rutgers University, Camden.
Former positions of Joseph Hooker
| Companies | Position | End |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Chief Executive Officer | 2023-08-10 |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2020-09-30 |
| BIOGEN INC. | Corporate Officer/Principal | 2019-02-28 |
Pierian Biosciences LLC
 Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN. | Chief Tech/Sci/R&D Officer | 2018-01-31 |
| MedAvante-ProPhase, Inc. | Chief Operating Officer | 2017-07-31 |
Training of Joseph Hooker
| Rider University | Masters Business Admin |
| Rutgers University, Camden | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
| MedAvante-ProPhase, Inc. | |
Pierian Biosciences LLC
Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN. | Health Services |
| Sandoz Biopharmaceuticals |
- Stock Market
- Insiders
- Joseph Hooker